Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Periprosthetic hypoxia as consequence of TRPM7 mediated cobalt influx in osteoblasts.

Römmelt C, Munsch T, Drynda A, Lessmann V, Lohmann CH, Bertrand J.

J Biomed Mater Res B Appl Biomater. 2019 Aug;107(6):1806-1813. doi: 10.1002/jbm.b.34273. Epub 2018 Dec 3.

PMID:
30508321
2.

Differential Effect of Cobalt and Chromium Ions as Well as CoCr Particles on the Expression of Osteogenic Markers and Osteoblast Function.

Drynda A, Drynda S, Kekow J, Lohmann CH, Bertrand J.

Int J Mol Sci. 2018 Oct 5;19(10). pii: E3034. doi: 10.3390/ijms19103034.

3.

The effects of cobalt and chromium ions on transforming growth factor-beta patterns and mineralization in human osteoblast-like MG63 and SaOs-2 cells.

Drynda S, Drynda A, Feuerstein B, Kekow J, Lohmann CH, Bertrand J.

J Biomed Mater Res A. 2018 Aug;106(8):2105-2115. doi: 10.1002/jbm.a.36409. Epub 2018 Apr 14.

PMID:
29577601
4.

Immunoregulatory effects of 4-(4-chlorophenyl)-1-(5-amino-3-methylisoxazole-4-carbonyl)-thiosemicarbazide (06K) in non-immunized and SRBC-immunized mice.

Drynda A, Obmińska-Mrukowicz B, Zaczyńska E, Zimecki M, Ryng S, Mączyński M.

J Pharm Pharmacol. 2016 Dec;68(12):1613-1620. doi: 10.1111/jphp.12631. Epub 2016 Oct 26.

PMID:
27781279
5.

5-Amino-3-methyl-4-isoxazolecarboxylic acid hydrazide derivatives with in vitro immunomodulatory activities.

Drynda A, Obmińska-Mrukowicz B, Zaczyńska E, Zimecki M, Kochanowska I, Ryng S, Mączyński M.

Chem Biol Drug Des. 2017 May;89(5):705-713. doi: 10.1111/cbdd.12892. Epub 2016 Nov 24.

PMID:
27779824
6.

The induction of CXCR4 expression in human osteoblast-like cells (MG63) by CoCr particles is regulated by the PLC-DAG-PKC pathway.

Drynda A, Ren Q, Buchhorn GH, Lohmann CH.

J Biomed Mater Res B Appl Biomater. 2017 Nov;105(8):2326-2332. doi: 10.1002/jbm.b.33770. Epub 2016 Aug 9.

PMID:
27504737
7.

New cytotoxic butyltin complexes with 2-sulfobenzoic acid: Molecular interaction with lipid bilayers and DNA as well as in vitro anticancer activity.

Pruchnik H, Kral T, Poradowski D, Pawlak A, Drynda A, Obmińska-Mrukowicz B, Hof M.

Chem Biol Interact. 2016 Jan 5;243:107-18. doi: 10.1016/j.cbi.2015.11.007. Epub 2015 Nov 14.

PMID:
26585592
8.

The effect of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide on lymphocyte subsets and humoral immune response in SRBC-immunized mice.

Drynda A, Obmińska-Mrukowicz B, Mączyński M, Ryng S.

Immunopharmacol Immunotoxicol. 2015 Apr;37(2):148-57. doi: 10.3109/08923973.2014.1000496. Epub 2015 Jan 9.

PMID:
25572572
9.

Metallic wear debris may regulate CXCR4 expression in vitro and in vivo.

Drynda A, Singh G, Buchhorn GH, Awiszus F, Ruetschi M, Feuerstein B, Kliche S, Lohmann CH.

J Biomed Mater Res A. 2015 Jun;103(6):1940-8. doi: 10.1002/jbm.a.35330. Epub 2014 Sep 17.

PMID:
25205627
10.

Immunophenotypic characterization of canine malignant lymphoma: a retrospective study of cases diagnosed in Poland Lower Silesia, over the period 2011-2013.

Pawlak A, Rapak A, Drynda A, Poradowski D, Zbyryt I, Dzimira S, Suchański J, Obmińska-Mrukowicz B.

Vet Comp Oncol. 2016 Aug;14 Suppl 1:52-60. doi: 10.1111/vco.12112. Epub 2014 Jul 23.

PMID:
25052381
11.

In vitro and in vivo corrosion properties of new iron-manganese alloys designed for cardiovascular applications.

Drynda A, Hassel T, Bach FW, Peuster M.

J Biomed Mater Res B Appl Biomater. 2015 Apr;103(3):649-60. doi: 10.1002/jbm.b.33234. Epub 2014 Jun 28.

PMID:
24976236
12.

In vitro immunomodulatory effects of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide on the cellular immune response.

Drynda A, Mączyński M, Ryng S, Obmińska-Mrukowicz B.

Immunopharmacol Immunotoxicol. 2014 Apr;36(2):150-7. doi: 10.3109/08923973.2014.890216. Epub 2014 Mar 4.

PMID:
24588616
13.

Biocompatibility of fluoride-coated magnesium-calcium alloys with optimized degradation kinetics in a subcutaneous mouse model.

Drynda A, Seibt J, Hassel T, Bach FW, Peuster M.

J Biomed Mater Res A. 2013 Jan;101(1):33-43. doi: 10.1002/jbm.a.34300. Epub 2012 Jul 6.

PMID:
22767427
14.

Histological and molecular evaluation of iron as degradable medical implant material in a murine animal model.

Mueller PP, Arnold S, Badar M, Bormann D, Bach FW, Drynda A, Meyer-Lindenberg A, Hauser H, Peuster M.

J Biomed Mater Res A. 2012 Nov;100(11):2881-9. doi: 10.1002/jbm.a.34223. Epub 2012 May 24.

PMID:
22623368
15.

Influence of Fe(II) and Fe(III) on the expression of genes related to cholesterol- and fatty acid metabolism in human vascular smooth muscle cells.

Drynda A, Hoehn R, Peuster M.

J Mater Sci Mater Med. 2010 May;21(5):1655-63. doi: 10.1007/s10856-010-4014-8. Epub 2010 Feb 17.

PMID:
20162334
16.

Development and biocompatibility of a novel corrodible fluoride-coated magnesium-calcium alloy with improved degradation kinetics and adequate mechanical properties for cardiovascular applications.

Drynda A, Hassel T, Hoehn R, Perz A, Bach FW, Peuster M.

J Biomed Mater Res A. 2010 May;93(2):763-75. doi: 10.1002/jbm.a.32582.

PMID:
19653306
17.

Common signatures for gene expression in postnatal patients with patent arterial ducts and stented arteries.

Mueller PP, Drynda A, Goltz D, Hoehn R, Hauser H, Peuster M.

Cardiol Young. 2009 Aug;19(4):352-9. doi: 10.1017/S1047951109004260. Epub 2009 Jun 19.

PMID:
19538825
18.
19.

Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept.

Koczan D, Drynda S, Hecker M, Drynda A, Guthke R, Kekow J, Thiesen HJ.

Arthritis Res Ther. 2008;10(3):R50. doi: 10.1186/ar2419. Epub 2008 May 2.

20.

Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.

Meinecke I, Cinski A, Baier A, Peters MA, Dankbar B, Wille A, Drynda A, Mendoza H, Gay RE, Hay RT, Ink B, Gay S, Pap T.

Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5073-8. Epub 2007 Mar 14.

21.

Gene transfer of tissue inhibitor of metalloproteinases-3 reverses the inhibitory effects of TNF-alpha on Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.

Drynda A, Quax PH, Neumann M, van der Laan WH, Pap G, Drynda S, Meinecke I, Kekow J, Neumann W, Huizinga TW, Naumann M, König W, Pap T.

J Immunol. 2005 May 15;174(10):6524-31.

22.

Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy.

Drynda S, Ringel B, Kekow M, Kühne C, Drynda A, Glocker MO, Thiesen HJ, Kekow J.

Pathol Res Pract. 2004;200(2):165-71.

PMID:
15237925
23.

Higher susceptibility to Fas ligand induced apoptosis and altered modulation of cell death by tumor necrosis factor-alpha in periarticular tenocytes from patients with knee joint osteoarthritis.

Machner A, Baier A, Wille A, Drynda S, Pap G, Drynda A, Mawrin C, Bühling F, Gay S, Neumann W, Pap T.

Arthritis Res Ther. 2003;5(5):R253-61. Epub 2003 Jun 30.

24.

The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma.

König B, Steinbach F, Janocha B, Drynda A, Stumm M, Philipp C, Allhoff EP, König W.

Anticancer Res. 1999 Mar-Apr;19(2C):1519-24.

PMID:
10365136
26.
27.

Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors.

Valsesia-Wittmann S, Drynda A, Deléage G, Aumailley M, Heard JM, Danos O, Verdier G, Cosset FL.

J Virol. 1994 Jul;68(7):4609-19.

28.

Use of helper cells with two host ranges to generate high-titer retroviral vectors.

Cosset FL, Girod A, Flamant F, Drynda A, Ronfort C, Valsesia S, Molina RM, Faure C, Nigon VM, Verdier G.

Virology. 1993 Mar;193(1):385-95.

PMID:
8382402
29.

Packaging cells for avian leukosis virus-based vectors with various host ranges.

Cosset FL, Ronfort C, Molina RM, Flamant F, Drynda A, Benchaibi M, Valsesia S, Nigon VM, Verdier G.

J Virol. 1992 Sep;66(9):5671-6.

30.

In situ expression of helper-free avian leukosis virus (ALV)-based retrovirus vectors in early chick embryos.

Thomas JL, Afanassieff M, Cosset FL, Molina RM, Ronfort C, Drynda A, Legras C, Chebloune Y, Nigon VM, Verdier G.

Int J Dev Biol. 1992 Jun;36(2):215-27.

31.

Newcastle disease virus (NDV) vaccine based on immunization with avian cells expressing the NDV hemagglutinin-neuraminidase glycoprotein.

Cosset FL, Bouquet JF, Drynda A, Chebloune Y, Rey-Senelonge A, Kohen G, Nigon VM, Desmettre P, Verdier G.

Virology. 1991 Dec;185(2):862-6.

PMID:
1660204
32.

Immune response and resistance to Rous sarcoma virus challenge of chickens immunized with cell-associated glycoproteins provided with a recombinant avian leukosis virus.

Chebloune Y, Rulka J, Cosset FL, Valsesia S, Ronfort C, Legras C, Drynda A, Kuzmak J, Nigon VM, Verdier G.

J Virol. 1991 Oct;65(10):5374-80.

Supplemental Content

Loading ...
Support Center